This announcement is a separate document:
博安生物：自願性公告腫瘤領域地舒單抗注射液（博洛加）獲國家藥品監督管理局批准上市
BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTDENOSUMAB INJECTION (BOLUOJIA) FOR ONCOLOGYINDICATIONS APPROVED FOR MARKETING BY NMPA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.